PRIO WEALTH LIMITED PARTNERSHIP - MIRAGEN THERAPEUTICS INC ownership

MIRAGEN THERAPEUTICS INC's ticker is MGEN and the CUSIP is 60463E103. A total of 59 filers reported holding MIRAGEN THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRIO WEALTH LIMITED PARTNERSHIP ownership history of MIRAGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$26,000
-25.7%
12,8950.0%0.00%
-50.0%
Q1 2019$35,000
-10.3%
12,8950.0%0.00%0.0%
Q4 2018$39,000
-45.1%
12,8950.0%0.00%
-33.3%
Q3 2018$71,000
-13.4%
12,8950.0%0.00%
-25.0%
Q2 2018$82,000
-8.9%
12,8950.0%0.00%0.0%
Q1 2018$90,000
-32.8%
12,8950.0%0.00%
-33.3%
Q4 2017$134,000
+14.5%
12,8950.0%0.01%0.0%
Q3 2017$117,00012,8950.01%
Other shareholders
MIRAGEN THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 3,142,580$1,414,0001.91%
Game Plan Financial Advisors, LLC 44,550$17,0000.02%
Alyeska Investment Group, L.P. 743,398$332,0000.01%
Alyeska Investment Group, L.P. 500,000$223,0000.00%
Aveo Capital Partners, LLC 16,732$7,0000.00%
Squarepoint Ops LLC 67,258$30,0000.00%
MERCER GLOBAL ADVISORS INC /ADV 13,121$6,0000.00%
PANAGORA ASSET MANAGEMENT INC 2,261$1,0000.00%
GOLDMAN SACHS GROUP INC 51,297$23,0000.00%
BNP PARIBAS FINANCIAL MARKETS 154$69,0000.00%
View complete list of MIRAGEN THERAPEUTICS INC shareholders